Knight Therapeutics (GUD) Stock Chart & Stock Price History C$6.05 +0.03 (+0.50%) As of 07/4/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Knight Therapeutics Stock Price Performance The Knight Therapeutics (GUD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 6.33%, with a year-to-date return of 13.30%. In the past month, the stock has increased 0.50%, reflecting recent market activity. As of the latest close, Knight Therapeutics traded at C$6.02 with a market cap of C$608.92 million and volume of 121,652 shares. Five years ago, the stock traded at C$7.03, representing a 13.94% decrease over that period. At the time, it had a market cap of C$937.03 million and a volume of 953,589 shares. Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.77%1 Month Performance+0.50%3 Month Performance+3.24%Year-To-Date Performance+13.30%1 Year Performance+6.33%5 Year Performance-13.94% GUD Stock Chart for Saturday, July, 5, 2025 GUD Chart by TradingView Knight Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025C$6.02C$6.05+0.50%C$6.06C$6.019,509 shsC$611.96 million07/03/2025C$6.00C$6.02+0.33%C$6.05C$5.97121,652 shsC$608.92 million07/02/2025C$5.83C$6.00+2.92%C$6.02C$5.8150,813 shsC$606.90 million07/01/2025C$5.83C$5.83C$5.87C$5.7519,898 shsC$589.71 million06/30/2025C$5.75C$5.83+1.39%C$5.87C$5.7519,898 shsC$589.71 million06/27/2025C$5.75C$5.75C$5.77C$5.75117,529 shsC$581.61 million06/26/2025C$5.76C$5.75-0.17%C$5.83C$5.7372,968 shsC$581.61 million06/25/2025C$5.80C$5.76-0.69%C$5.81C$5.7633,813 shsC$582.62 million06/24/2025C$5.81C$5.80-0.17%C$5.85C$5.7531,753 shsC$586.67 million06/23/2025C$5.85C$5.81-0.68%C$5.91C$5.818,767 shsC$587.68 million Get the Latest News and Ratings for GUD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025C$5.84C$5.85+0.17%C$5.95C$5.8226,608 shsC$591.73 million06/19/2025C$5.94C$5.84-1.68%C$6.01C$5.8418,569 shsC$590.72 million06/18/2025C$6.07C$5.94-2.14%C$6.17C$5.9426,789 shsC$600.83 million06/17/2025C$6.02C$6.07+0.83%C$6.16C$6.02951,769 shsC$613.98 million06/16/2025C$6.03C$6.02-0.17%C$6.08C$6.0118,608 shsC$608.92 million06/13/2025C$6.09C$6.03-0.99%C$6.06C$5.9741,423 shsC$609.94 million06/12/2025C$6.00C$6.09+1.50%C$6.10C$6.0046,921 shsC$616.00 million06/11/2025C$6.04C$6.00-0.66%C$6.08C$6.0023,866 shsC$606.90 million06/10/2025C$6.02C$6.04+0.33%C$6.07C$5.9748,433 shsC$610.95 million06/09/2025C$6.00C$6.02+0.33%C$6.11C$6.0272,371 shsC$608.92 million06/06/2025C$6.02C$6.00-0.33%C$6.07C$5.9937,202 shsC$606.90 million06/05/2025C$5.82C$6.02+3.44%C$6.06C$5.84112,470 shsC$608.92 million06/04/2025C$5.80C$5.82+0.34%C$5.85C$5.8041,043 shsC$588.69 million Related Companies BHC Stock Price Chart CRON Stock Price Chart TLRY Stock Price Chart ACB Stock Price Chart WEED Stock Price Chart CPH Stock Price Chart OGI Stock Price Chart CRDL Stock Price Chart RX Stock Price Chart HLS Stock Price Chart Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:GUD) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
